Programme

Max spent his early childhood travelled extensively with family following fathers career and experiencing different cultures including time in Spain, France, UK, Malta, Africa, US, Canada, Australia, Canary Islands and New Zealand. Educated primarily in Auckland, New Zealand Max studied life sciences and has a post-graduate degree in Marine Biology. Following some years in the Navy, Max joined Schering-Plough pharmaceuticals as sales representative in 1991, progressed to marketing department and subsequently joined a healthcare advertising agency. Max progressed rapidly through various roles and different companies in same group – managing his first company in 1995. Promoted to President Europe for Medicus Group in 1999, and added Asia Pacific responsibilities a year later. Medicus Group’s holding company was acquired by Publicis in 2002, and was promoted to President EMEA and APAC for Publicis Healthcare Group, responsible for both Medicus Group and Saatchi & Saatchi Healthcare operations outside North America. Max Joined Sudler&Hennessey in 2008 as Head of EMEA, taking the role of CEO, EMEA and APAC in 2010. Max has moderated innumerable advisory panels, workshops, symposia, stand-alone meetings and internal motivation sessions. Max now lives in Moscow although he travels extensively and has three children. he enjoys running/weight training) diving, sailing, skiing, squash. In his spare he is attempting to learn Russian.

Arman Voskerchyan was born in 1968, in Armenia. He graduated from the Yerevan State Medical University with pediatrics degree. He started post-graduate studies and also worked as an anesthesiologist at the Filatov children’s hospital in Moscow. In 1998, he presented his Ph.D. Anesthesiology and Reanimatology thesis at Russian State Medical University. In 2005, Arman Voskerchyan earned his Executive MBA degree from the Harvard Business School. Since 1998, Arman has worked for Johnson & Johnson LLC. He consistently occupied management positions for the company’s business development in Russia and the CIS countries. In 2005, he became Strategic Planning Director for the company’s medical devices and diagnostics division (MD&D). In 2006, Arman Voskerchyan was named Director for Business Development for one of the leading medical business divisions of the company – Ethicon (surgical instruments, equipment and materials) for the Europe, Middle East and Africa region. Since 2007, Arman has been the General Director of Johnson & Johnson LLC for Russia and the CIS and the Managing Director of its MD&D division. Arman Voskerchyan was one of the founders of IMEDA in Russia. He actively participated as one of the authors of the Association’s Code of Ethics, which sets high standards of transparency in the medical equipment industry. In 2008 he became the Chairman of IMEDA’s Board of Directors. In addition, Arman also co-chairs the Health Committee of the American Chamber of Commerce in Russia. In 2013, Mr. Voskerchyan was appointed Senior Vice President, Healthcare Sector Leader of Philips Russia, Ukraine, Belarus & Central Asia. On February 1, 2015 Arman Voskerchyan became CEO Philips Russia, Belarus, South Caucasus & Central Asia, as well as Senior Vice President of the company, retaining the position of the head of the Healthcare sector

Alberto Colzi earned his Engineering degree from Pisa University in Italy, and his post-graduate degree in Business Administration from Durham University, United Kingdom.Alberto Colzi joined Abbott Italy in 1991. Until 1998, he held various positions in the Marketing and Service organization. In 1998, Mr. Colzi was promoted to Commercial Director, Latin America and in 1999 was named General Manager, Abbott Chile. In 2004, he was promoted to Regional Director, Southern Europe and in 2006 he was named General Manager, Abbott Italy.In 2010, Mr. Colzi was appointed Vice President, Central and Eastern Europe, the Middle East and Africa, and in 2013, he became responsible for Eastern Europe, Middle East & Africa Operations for AbbVie, shortly following the separation of Abbott into two publicly traded companies: Abbott and AbbVie.

Mark Kurtser is the founder of the Mother and Child Group of Companies, Chairman of the Group’s Board of Directors, a correspondent member of the Russian Academy of Sciences, a doctor of medicine and a professor. He began his career at the Department of Obstetrics and Gynaecology of the Pirogov Second Moscow State Medical Institute, where he worked his way up from assistant to associate professor of the department. From 1994 to 2012, Kurtser was head of the Family Planning and Reproduction Centre of the Moscow Healthcare Department, the largest obstetrics and gynaecology institution in Moscow. In 2011, he defended his doctoral dissertation. From 2003 to 2013, he was the chief obstetrician and gynaecologist within the Moscow Healthcare Department. The Mother and Child Welfare programme was prepared with his involvement as part of the Municipal Targeted Programme for Healthcare Development for 2006–2007 and guidelines were developed for health and demographic indicators. The level of maternal and perinatal mortality declined in the city. Kurtser is the author of 45 scientific works, more than eleven textbooks and practical guidelines in obstetrics and gynaecology. PhD dissertations are held under his guidance. Kurtser is actively involved in holding conventions and symposiums and also lectures for practicing physicians and residents. He introduces innovative medical technologies to the work of obstetrics and gynaecology in-patient clinics. Kurtser remains actively involved in the activities of the Mother and Child Group both as an executive and as regular medical practitioner.

Education: 1992, Moscow Medical Academy with distinction, c 2006 - Doctor of Medicine. Work Experience: 1991 – 2006, ROSNO Insurance Company since 2003 CEO and Chairman of the Board; 2006 – 2008, Mobile TeleSystems President and Chairman of the Board, member of the Board of Directors; 2008 – 2011, JSFC Sistema President and Chairman of the Management Board; 2011 – 2012, JSFC Sistema, Vice Chairman of the Board of Directors; 2010 – 2012, “RussNeft” Oil Company, Chairman of the Board of Directors; 2012 – 2013, VTB OJSC, member of the Supervisory Board. Leonid is a member of the Government Expert Council of the Russian Federation.

Born in Moscow, Russia on 27 August 1979.Graduated from the State University “Higher School of Economics”, Diploma in Economy and Business Administration.Since 1995 in Healthcare and Pharmaceutics.R-Pharm Founder. President of All-Russia Business Association “Delovaya Rossiya” (“Business Russia”), actively participating in the improvement of investment climate in the Russian Federation and the establishment of the regional investment standard.Member of the Economic Council under the President of the Russian Federation.Member of the Presidential Council for Priority National Projects and Demographic Policy.Member of the Expert Council under the Government of the Russian Federation. Member of the Public Chamber of the Russian Federation, Head of Commission on Investment Climate.Representative (public ombudsman) of the Commissioner of the Presidential Council on the protection of the rights of entrepreneurs on issues related to the protection of the rights of foreign investors.Board-member and Co-chairman of Committee of the Russian Union of Industrialists and Entrepreneurs on pharmaceutical and medical industry.Co-Chairman of the National Rating CommitteeMember of the Public Council under the Ministry of Industry and Trade of the Russian Federation (pharmaceutical, medical equipment and technologies).Member of the Supervisory Board of the Autonomous Nonprofit Organization "Agency for Strategic Initiatives".

Mr. Roytberg is the director of JSC Medicina as well as a practicing doctor and scientist. Grigory was at the forefront of the introduction of such fundamental diagnostics techniques such as coronary angiography and echocardiography. He is the founder of the scientific school for metabolic syndrome and the author of over 200 scientific papers, including six monographs. After graduating from the Pirogov Second Moscow Medical Institute in 1974, he took up clinical residency with a major in Cardiology. During his studies, he worked as a doctor in the cardiology department, and then in the cardiac intensive care unit of the Seventh Moscow City Hospital. In 1982, he defended his thesis and was awarded the title of associate professor. He obtained a Doctorate of Medical Sciences in 1990. In the same year under, the Medicina clinic was founded under Roitberg’s guidance. The Therapy and Family Medicine Department of Pirogov Russian National Research Medical University (RNRMU) has been working on the core of the Medicina clinic under the supervision of Mr. Roytberg since 1998. Mr. Roytberg was awarded the title of Honoured Doctor of the Russian Federation in 2003 and elected as a correspondent member of the Russian Academy of Medical Sciences in 2005. The textbook “Laboratory and Instrumental Diagnostics of Diseases of the Internal Organs”, which was prepared in collaboration with Professor A. Strutynsky, the chair of the RNRMU Propaedeutics of Internal Diseases Department, was awarded the Prize of the Moscow Mayor in medicine. In 2010, Mr. Roytberg was awarded the Prize of the RF Government in education for the series of works “Fundamentals of the clinical diagnosis of diseases of the internal organs”. In 2011, Grigory Roytberg was elected a member of the Russian Academy of Medical Sciences.